- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cigna Refers to NCCN Guidelines for Oncology Coverage Decisions
The Cigna-NCCN collaboration will benefit about 12.5 million members.
As part of the company's coverage policy development, Cigna is using the NCCN Guidelines(R) and the NCCN Compendium(R) as references in the appropriate choice for the treatment of people with cancer in the United States.
Cigna is using National Comprehensive Cancer Network® (NCCN®) Content as a resource for oncology coverage policy development and updates for the company's more than 840,000 providers throughout the United States.
"Cigna recognizes the important role that NCCN has in establishing standards and guidance for care in the area of cancer screening, diagnosis, treatment, and surveillance," said Julie B. Kessel, MD, Cigna's Senior Medical Director for Coverage Policy.
Read the report: http://cnnmon.ie/1vuxXYw
Source: CNN Money
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy
December 16th 2025The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.
Read More
